Skip to main content
SpringerLink
Log in

Bipolare Störungen

Ein Update

Bipolar Disorders

An Update

  • Psychiatrie
  • Published:
psychopraxis. neuropraxis Aims and scope Submit manuscript

Zusammenfassung

Die letzten drei Jahrzehnte waren charakterisiert durch eine bemerkenswerte Expansion diagnostischer und therapeutischer Optionen im Zusammenhang mit bipolar affektiven Störungen. Aktuell kann eine Konsolidierungsphase beobachtet werden mit weniger – vor allem pharmakologischen – Innovationen. Das vorliegende Manuskript widmet sich drei Fragen: Was gibt es Neues zur Diagnostik? Was gibt es Neues zur Pharmakotherapie? Was gibt es Neues zur Psychotherapeutischen Medizin? Die Fragen werden beantwortet, indem jeweils ein besonderer Aspekt hervorgehoben wird: die neue Klassifikation der Mischzustände im DSM-5, die Verwendung von Loxapin als Inhalat in der Therapie der Agitation und der Einsatz der „mindfulness-based cognitive therapy“ (MBCT) bei bipolaren Störungen.

Abstract

The last 3 decades were characterized by a remarkable expansion of diagnostic and therapeutic options in bipolar affective disorders. Recently, a phase of consolidation with less—particularly pharmacologic—innovation can be observed. In the present manuscript three questions are addressed: What’s new about diagnosis? What’s new about pharmacotherapy? What’s new about psychotherapeutic medicine? The questions are answered by highlighting one particular aspect each: the new classification of mixed states in DSM-5, the application of loxapine by inhalatory route in agitation and the use of mindfulness-based cognitive therapy in bipolar disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I (2018) Bipolar disorders. Nat Rev Dis Primers 4:18008

    Article  PubMed  Google Scholar 

  2. Cullen B, Ward J, Graham NA, Deary IJ, Pell JP, Smith DJ, Evans JJ (2016) Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder: a systematic review. J Affect Disord 205:165–181

    Article  PubMed  Google Scholar 

  3. Vigo D, Thornicroft G, Atun R (2016) Estimating the true global burden of mental illness. Lancet Psychiatry 3:171–178

    Article  PubMed  Google Scholar 

  4. Unseld M, Dworschak G, Tran US, Plener PL, Erfurth A, Walter H, Lesch OM, Kapusta ND (2012) The concept of temperament in psychoactive substance use among college students. J Affect Disord 141(2–3):324–330

    Article  PubMed  Google Scholar 

  5. Naderer A, Keller F, Plener P, Unseld M, Lesch OM, Walter H, Erfurth A, Kapusta ND (2015) The brief TEMPS-M temperament questionnaire: a psychometric evaluation in an Austrian sample. J Affect Disord 188:43–46

    Article  PubMed  CAS  Google Scholar 

  6. Skala K, Riegler A, Erfurth A, Völkl-Kernstock S, Lesch OM, Walter H (2016) The connection of temperament with ADHD occurrence and persistence into adulthood—an investigation in 18 year old males. J Affect Disord 198:72–77

    Article  PubMed  CAS  Google Scholar 

  7. Shahini M, Shala M, Xhylani P, Gashi S, Borinca I, Erfurth A (2018) Challenging predictions between affective temperaments, depression and anxiety in a Kosovo student community sample. Int J Psychiatry Clin Pract 26:1–7

    Article  Google Scholar 

  8. Vannucchi G, Masi G, Toni C, Dell’Osso L, Erfurth A, Perugi G (2014) Bipolar disorder in adults with Asperger’s Syndrome: a systematic review. J Affect Disord 168:151–160

    Article  PubMed  Google Scholar 

  9. Sachs G, Erfurth A (2018) Obsessive compulsive and related disorders: from the biological basis to a rational pharmacological treatment. Int J Neuropsychopharmacol 21(1):59–62

    Article  PubMed  Google Scholar 

  10. Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ (2001) Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 62(Suppl 14):34–41

    PubMed  Google Scholar 

  11. Erfurth A, Perugi G (2005) Rapid cycling. In: Kasper S, Hirschfeld RMA (Hrsg) Handbook of bipolar disorder. Marcel Dekker, Taylor & Francis Books, Inc, Abingdon, S 201–212

    Google Scholar 

  12. Michael N, Erfurth A, Pfleiderer B (2009) Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder. Psychiatry Res Neuroimag 172(1):78–81

    Article  CAS  Google Scholar 

  13. Carvalho AF, Dimellis D, Gonda X, Vieta E, Mclntyre RS, Fountoulakis KN (2014) Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry 75(6):e578–86

    Article  PubMed  Google Scholar 

  14. Erfurth A, Arolt V (2003) Das Spektrum bipolarer Störungen. Nervenarzt 73:55–71

    Article  Google Scholar 

  15. Weygandt W (1899) Über die Mischzustände des manisch-depressiven Irreseins. Lehmann, München

    Google Scholar 

  16. Kraepelin E (1899) Psychiatrie, 6. Aufl. Barth, Leipzig

    Google Scholar 

  17. Erfurth A (2004) Agitated depression is bipolar. PRO. J Bipolar Disord Rev Comment 3:4–14

    Google Scholar 

  18. Erfurth A, Sachs G, Perugi G, Tondo L (2014) Athanasios Koukopoulos (1931–2013). Zum Verlauf manisch-depressiver Erkrankungen. Psychoprax Neuroprax 17:5–8

    Article  Google Scholar 

  19. Perugi G, Angst J, Azorin JM, Bowden CL, Mosolov S, Reis J, Vieta E, Young AH, BRIDGE-II-Mix Study Group (2015) Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry 76(3):e351–8

    Article  PubMed  Google Scholar 

  20. American Psychiatric Association (2013) The diagnostic and statistical manual of mental disorders: DSM-5

    Book  Google Scholar 

  21. Erfurth A, Sachs G (2015) Mischzustände, Mischbilder und die depressive Episode mit gemischten Merkmalen. Psychoprax Neuroprax 18(2):38–43

    Article  Google Scholar 

  22. Kasper S, Kapfhammer HP, Bach M, Butterfield-Meissl C, Erfurth A, Haring C, Hausmann A, Hofmann P, Kalousek M, Klier C, Marksteiner J, Mühlbacher M, Oberlerchner H, Psota G, Rados C, Sachs GM, Windhager E, Winkler J, Wrobel M (2013) Bipolare Störungen. Konsensus-Statement—State of the art 2013. CliniCum neuropsy Sonderausgabe November, S 3–18

    Google Scholar 

  23. Erfurth A, Grunze H (1998) New perspectives in the treatment of acute mania: a single case report. Prog Neuropsychopharmacol Biol Psychiatry 22(6):1053–1059

    Article  PubMed  CAS  Google Scholar 

  24. Erfurth A, Kuhn G (2000) Topiramate monotherapy in the maintenance treatment of bipolar I disorder: effects on mood, weight and serum lipids. Neuropsychobiology 42(Suppl 1):50–51

    Article  PubMed  CAS  Google Scholar 

  25. Kasper S, Baranyi A, Eisenburger P, Erfurth A, Ertl M, Frey R, Hausmann A, Kapfhammer HP, Roitner-Vitzthum E, Konsensus-Statement WD (2013) Die Behandlung der Agitation beim psychiatrischen Notfall. CliniCum neuropsy Sonderausgabe November, S 3–15

    Google Scholar 

  26. Brown R, Taylor MJ, Geddes J (2013) Aripiprazole alone or in combination for acute mania. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005000.pub2

    Article  PubMed  Google Scholar 

  27. Grande I, Hidalgo-Mazzei D, Nieto E, Mur M, Sàez C, Forcada I, Vieta E (2015) Asenapine prescribing patterns in the treatment of manic in- and outpatients: results from the MANACOR study. Eur Psychiatry 30(4):528–534

    Article  PubMed  CAS  Google Scholar 

  28. Popovic D, Nuss P, Vieta E (2015) Revisiting loxapine: a systematic review. Ann Gen Psychiatry 14:15

    Article  PubMed  PubMed Central  Google Scholar 

  29. Vieta E, Grunze H, Azorin JM, Fagiolini A (2014) Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: results from the IMPACT self-reported online survey. J Affect Disord 156:206–213

    Article  PubMed  Google Scholar 

  30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33

    PubMed  Google Scholar 

  31. Hergueta T, Weiller E (2013) Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 „With Mixed Features“ specifier. Int J Bipolar Disord 1:21

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fishman R, Spyker DA, Kehne JH, Cassella JV (2011) Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry 198(1):51–58

    Article  PubMed  Google Scholar 

  33. Kwentus J, Riesenberg RA, Marandi M, Manning RA, Allen MH, Fishman RS, Spyker DA, Kehne JH, Cassella JV (2012) Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord 14(1):31–40

    Article  PubMed  CAS  Google Scholar 

  34. Amodeo G, Fagiolini A, Sachs G, Erfurth A (2017) Older and newer strategies for the pharmacological management of agitation in patients with bipolar disorder or schizophrenia. Cns Neurol Disord Drug Targets 16(8):885–890

    PubMed  CAS  Google Scholar 

  35. Erfurth A (2017) Agitation: a central challenge in psychiatry. World J Biol Psychiatry 18(1):3–4

    Article  PubMed  Google Scholar 

  36. Kasper S, Di Pauli J, Erfurth A, Geretsegger C, Kapfhammer HP, Papageorgiou K, Sachs GM, Wrobel M (2015) Inhalatives Loxapin – Praxiserfahrungen nach dem ersten Anwendungsjahr. CliniCum neuropsy Sonderausgabe 2015

    Google Scholar 

  37. Glazer WM (1999) Does loxapine have „atypical“ properties? Clinical evidence. J Clin Psychiatry 60(Suppl 10):42–46

    PubMed  CAS  Google Scholar 

  38. Spyker DA, Munzar P, Cassella JV (2010) Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers. J Clin Pharmacol 50(2):169–179

    Article  PubMed  CAS  Google Scholar 

  39. Schaub A, Bernhard B, Gauck L (2004) Kognitiv-psychoedukative Therapie bei bipolaren Erkrankungen: Ein Therapiemanual. Hogrefe, Göttingen

    Google Scholar 

  40. Erfurth A, Dobmeier G, Zechendorff M (2005) Kurzpsychoedukation für bipolare Patienten: das einfache Kurzprogramm in 6 Modulen. Thieme, Stuttgart

    Google Scholar 

  41. Meyer TD, Bipolare Störungen HM (2013) Kognitiv-verhaltenstherapeutisches Behandlungsmanual. Beltz, Weinheim

    Google Scholar 

  42. Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG (2016) Empirically supported psychosocial interventions for bipolar disorder: current state of the research. J Affect Disord 201:203–214

    Article  PubMed  Google Scholar 

  43. Vieta E, Torrent C (2016) Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry 15:288–289

    Article  PubMed  PubMed Central  Google Scholar 

  44. Sachs G, Felsberger H (2013) Mentalisierungsbasierte Psychotherapie bei schizophrenen Psychosen. Psychotherapeut 58(4):339–343

    Article  Google Scholar 

  45. Sachs G, Volz HP (Hrsg) (2012) Neurokognition und Affektregulierung bei schizophrenen Psychosen: Neuropsychologie, Bildgebung, Testdiagnostik und Behandlung. Schattauer, Stuttgart

    Google Scholar 

  46. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61(1):34–41

    Article  PubMed  Google Scholar 

  47. Ye BY, Jiang ZY, Li X, Cao B, Cao LP, Lin Y, Xu GY, Miao GD (2016) Effectiveness of cognitive behavioral therapy in treating bipolar disorder: an updated meta-analysis with randomized controlled trials. Psychiatry Clin Neurosci 70(8):351–361

    Article  PubMed  Google Scholar 

  48. Luders E, Toga AW, Lepore N, Gaser C (2009) The underlying anatomical correlates of long-term meditation: larger hippocampal and frontal volumes of gray matter. Neuroimage 45(3):672–678

    Article  PubMed  PubMed Central  Google Scholar 

  49. Luders E, Thompson PM, Kurth F, Hong JY, Phillips OR, Wang Y, Gutman BA, Chou YY, Narr KL, Toga AW (2013) Global and regional alterations of hippocampal anatomy in long-term meditation practitioners. Hum Brain Mapp 34(12):3369–3375

    Article  PubMed  Google Scholar 

  50. Tang YY, Lu Q, Feng H, Tang R, Posner MI (2015) Short-term meditation increases blood flow in anterior cingulate cortex and insula. Front Psychol 6:212

    Article  PubMed  PubMed Central  Google Scholar 

  51. Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L, Bloch R, Levitan RD (2010) Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry 67(12):1256–1264

    Article  PubMed  PubMed Central  Google Scholar 

  52. Piet J, Hougaard E (2011) The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 31(6):1032–1040

    Article  PubMed  Google Scholar 

  53. Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Brejcha C, Cardy J, Causley A, Cowderoy S, Evans A, Gradinger F, Kaur S, Lanham P, Morant N, Richards J, Shah P, Sutton H, Vicary R, Weaver A, Wilks J, Williams M, Taylor RS, Byford S (2015) Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 386(9988):63–73

    Article  PubMed  Google Scholar 

  54. Williams JM, Alatiq Y, Crane C, Barnhofer T, Fennell MJ, Duggan DS, Hepburn S, Goodwin GM (2008) Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. J Affect Disord 107(1–3):275–279

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Weber B, Jermann F, Gex-Fabry M, Nallet A, Bondolfi G, Aubry JM (2010) Mindfulness-based cognitive therapy for bipolar disorder: a feasibility trial. Eur Psychiatry 25(6):334–337

    Article  PubMed  CAS  Google Scholar 

  56. Deckersbach T, Hölzel BK, Eisner LR, Stange JP, Peckham AD, Dougherty DD, Rauch SL, Lazar S, Nierenberg AA (2012) Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder. CNS Neurosci Ther 18(2):133–141

    Article  PubMed  Google Scholar 

  57. Stange JP, Eisner LR, Hölzel BK, Peckham AD, Dougherty DD, Rauch SL, Nierenberg AA, Lazar S, Deckersbach T (2011) Mindfulness-based cognitive therapy for bipolar disorder: effects on cognitive functioning. J Psychiatr Pract 17(6):410–419

    Article  PubMed  PubMed Central  Google Scholar 

  58. Perich T, Manicavasagar V, Mitchell PB, Ball JR, Hadzi-Pavlovic D (2013) A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder. Acta Psychiatr Scand 127(5):333–343

    Article  PubMed  CAS  Google Scholar 

  59. Perich T, Manicavasagar V, Mitchell PB, Ball JR (2013) The association between meditation practice and treatment outcome in mindfulness-based cognitive therapy for bipolar disorder. Behav Res Ther 51(7):338–343

    Article  PubMed  Google Scholar 

  60. Ives-Deliperi VL, Howells F, Stein DJ, Meintjes EM, Horn N (2013) The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: a controlled functional MRI investigation. J Affect Disord 150(3):1152–1157

    Article  PubMed  Google Scholar 

  61. Cotton S, Luberto CM, Sears RW, Strawn JR, Stahl L, Wasson RS, Blom TJ, Delbello MP (2016) Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: a pilot trial. Early Interv Psychiatry 10(5):426–434

    Article  PubMed  Google Scholar 

  62. Lahera G, Bayón C, Bravo-Ortiz FM, Rodríguez-Vega B, Barbeito S, Sáenz M, Avedillo C, Villanueva R, Ugarte A, González-Pinto A, de Dios C (2014) Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial. BMC Psychiatry 14:215

    Article  PubMed  PubMed Central  Google Scholar 

  63. Joshi SS, Sharma MP, Varambally S (2018) Effectiveness of mindfulness-based cognitive therapy in patients with bipolar affective disorder: a case series. Int J Yoga 11(1):77–82

    PubMed  PubMed Central  Google Scholar 

  64. Weber B, Sala L, Gex-Fabry M, Docteur A, Gorwood P, Cordera P, Bondolfi G, Jermann F, Aubry JM, Mirabel-Sarron C (2017) Self-reported long-term benefits of mindfulness-based cognitive therapy in patients with bipolar disorder. J Altern Complement Med 23(7):534–540

    Article  PubMed  Google Scholar 

  65. Bojic S, Becerra R (2017) Mindfulness-based treatment for bipolar disorder: a systematic review of the literature. Eur J Psychol 13(3):573–598

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 6. Psychiatrische Abteilung, Otto-Wagner-Spital, Baumgartner Höhe 1, 1140, Wien, Österreich

    Andreas Erfurth

  2. Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien, Wien, Österreich

    Gabriele Sachs

Authors
  1. Andreas Erfurth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriele Sachs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Erfurth.

Ethics declarations

Interessenkonflikt

A. Erfurth erhielt Referentenhonorare beziehungsweise war im Beirat oder als Berater tätig für: Angelini, AOP Orphan, Eli Lilly, Ferrer, Germania, Krka, Lundbeck, Neuraxpharm, GlaxoSmithKline, Pfizer, Janssen. G. Sachs erhielt Referentenhonorare beziehungsweise war im Beirat oder als Berater tätig für: Angelini, AOP Orphan, Alkermes, Lundbeck, Pfizer, Janssen.

Dieser Beitrag stellt keine von den Autoren durchgeführte Studie an Menschen oder Tieren dar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erfurth, A., Sachs, G. Bipolare Störungen. psychopraxis. neuropraxis 21, 123–127 (2018). https://doi.org/10.1007/s00739-018-0470-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00739-018-0470-6

Schlüsselwörter

Keywords

Search

Navigation